Abstract:Objective: This study aimed to systematically review the status and trends of Chinese clinical practice guidelines (CPGs) during the time period 2010–2020 and explore their methodological characteristics. Then, based on the strengths and weaknesses in development, offer several recommendations for the quality improvement which will serve as a reference for the users and developers of CPG. Introduction: With the development of evidence-based medicine (EBM), the CPGs play an increasingly important role in healthcare decision-making both in China and worldwide. Inclusion criteria: The CPGs that have been used to help the health professionals in the healthcare decision-making were included. Methodology: The China National Knowledge Infrastructure (CNKI) and WanFang databases were searched from 2010 to 2020 for the studies describing the general and methodological characteristics of Chinese CPGs. Comparisons of the methodological characteristics between the groups were conducted using the chi-square test or Fisher's exact test. The M-K test was adopted to identify the monotonically increasing or decreasing trends of methodological characteristics over the timespan. Results: A total of 2,654 CPGs fulfilled the inclusion criteria. The quantity and quality of the guidelines developed in China have improved over the time span. From 2010 to 2020,the guidelines had differing characteristics and covered a wide range of subjects. In total, 2,318(87.34%) guidelines focused on Western Medicine. Eight (0.30%) had been developed for patient versions of guidelines, 10(0.38%) were tentative guidelines, and 16(0.60%) were rapid advice guidelines. Medical specialty societies (including their branches) (71.1%) were the main guideline makers. The most addressed diseases were neoplasms (14.43%). The target population is mainly adults (84.97%). The methodological quality of consensus-based (CB)-CPGs was obviously lower than evidence-based (EB)-CPGs. Except for the item, “recommendations were based on evidence of systematic reviews,” there were statistical differences in all other methodological items between the EB-CPGS and CB-CPGS ( P < 0.01). Higher methodological quality has been observed in EB-CPGs. All the data relating to the methodological characteristics indicated that higher methodological quality was present in the guidelines using GRADE ( P < 0.01). Conclusion: The quantity and quality of the guidelines developed in China have improved between 2010 and 2020. CB-CPGs have also paid attention to the methodology quality, but obviously, this is lower than that in the EB-CPGs.

Analysis of the Status of Chinese clinical practice guidelines development

Quality Assessment of Clinical Guidelines in China: 1993 - 2010.

Analysis of the Status and Trends of Chinese Clinical Practice Guideline Development Between 2010 and 2020: A Systematic Review

The Quality of Clinical Practice Guidelines in China: a Systematic Assessment.

Clinical Epidemiology in China Series. Paper 4: the Reporting and Methodological Quality of Chinese Clinical Practice Guidelines Published Between 2014 and 2018: A Systematic Review.

Analysis of Development Method of Clinical Practice Guidelines in Primary Care

Analysis of Clinical Guidelines Developed Based on Evidence in China

P044 Quality Assessment of Traditional Chinese Clinical Guidelines: 2003–2012

Analysis on status of clinical guidelines and evaluation on evidence-based guidelines of children in China

Investigation and Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019: Analysis of the Evidence

The development of clinical guidelines in China: insights from a national survey

[Development of Clinical Practice Guidelines: Procedure and Standard].

Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China

P284 A Survey of the Updating of Clinical Practice Guidelines in China

Quality Appraisal of Clinical Practice Guidelines for Diabetes Mellitus Published in China Between 2007 and 2017 Using the AGREE II Instrument.

Using AGREE II to Evaluate the Quality of Traditional Medicine Clinical Practice Guidelines in China.

Clinical practice guideline in China: current status and thoughts

Clinical Practice Guidelines for Hypertension in China: A Systematic Review of the Methodological Quality

Guideline for [clinical Guidelines Constitution/Amendment] in China.

Development and Preliminary Verification of the Evaluation System for Clinical Practice Guidelines in China

Evaluation of Chinese Clinical Practice Guideline/consensus for Digestive Diseases